Romolisiran

Romolisiran is a sulfotransferase 15 (CHST15) synthesis inhibitor. CHST15 is upregulated in fibrosis (lung, liver, kidney), tumor stroma and inflammation; chondroitin sulfate chains modified by its product participate in TGF-β activation, collagen cross-linking and fibroblast activation. Romolisiran can be used to study diseases associated with fibrosis/stromal modification.

Nur für Forschungszwecke. Wir verkaufen nicht an Patienten.

  • CAS. Nr.: 3083163-26-9
  • Formel: C514H635N203O373P52
  • Molecular Weight:17235.29
  • Speicherung:

    Please store the product under the recommended conditions in the Certificate of Analysis.

  • Biologische Aktivität
  • Chemical Information
  • Protokoll
  • Reinheit & Dokumentation
  • Verweise
  • Help & FAQs

Alle SULT Isoform-spezifische Produkte anzeigen

More
MOQ
Minimum order quantity
100 mg

Angebot einholen Auf Lager

Other size
Angebot einholen
Please select quantity
Amount: USD 0.00